scope:

The recommendations set forth in this document are intended to be used by individuals involved in the following:

analyzing and presenting antimicrobial susceptibility test data (eg, clinical microbiologists, pharmacists, physicians);

utilizing cumulative antimicrobial susceptibility test data to make clinical decisions (eg, clinical microbiologists, infectious disease specialists and other clinicians, infection control practitioners, pharmacists, epidemiologists, other health care personnel, and public health officials); and

designing information systems for the storage and analysis of antimicrobial susceptibility test data (eg, laboratory information system [LIS] vendors, manufacturers of diagnostic products that include epidemiology software packages).